[{"notes_id":"1_452","category":"5","subcategory":"1","title":"Tuberculosis: management","body":"The standard therapy for treating <b>active tuberculosis<\/b> is:<br \/><br \/>Initial phase - first 2 months (RIPE)<br \/><ul><li>Rifampicin<\/li><li>Isoniazid<\/li><li>Pyrazinamide<\/li><li>Ethambutol (the 2006 NICE guidelines now recommend giving a 'fourth drug' such as ethambutol routinely - previously this was only added if drug-resistant tuberculosis was suspected)<\/li><\/ul><br \/>Continuation phase - next 4 months<br \/><ul><li>Rifampicin<\/li><li>Isoniazid<\/li><\/ul><br \/>The treatment for <b>latent tuberculosis<\/b> is 3 months of isoniazid (with pyridoxine) and rifampicin OR 6 months of isoniazid (with pyridoxine)<br \/><br \/>Patients with <b>meningeal tuberculosis<\/b> are treated for a prolonged period (at least 12 months) with the addition of steroids<br \/><br \/><b>Directly observed therapy<\/b> with a three times a week dosing regimen may be <br \/>indicated in certain groups, including:<br \/><ul><li>homeless people with active tuberculosis<\/li><li>patients who are likely to have poor concordance<\/li><li>all prisoners with active or latent tuberculosis<\/li><\/ul><br \/><br \/><h5 class='notes-heading'>Complications of treatment<\/h5><br \/>Immune reconstitution disease<br \/><ul><li>occurs typically 3-6 weeks after starting treatment<\/li><li>often presents with enlarging lymph nodes<\/li><\/ul><br \/>Drug adverse effects<br \/><ul><li>rifampicin<ul><li>potent liver enzyme inducer<\/li><li>hepatitis, orange secretions<\/li><li>flu-like symptoms<\/li><\/ul><\/li><li>isoniazid<ul><li>peripheral neuropathy: prevent with pyridoxine (Vitamin B6)<\/li><li>hepatitis, agranulocytosis<\/li><li>liver enzyme inhibitor<\/li><\/ul><\/li><li>pyrazinamide<ul><li>hyperuricaemia causing gout<\/li><li>arthralgia, myalgia<\/li><li>hepatitis<\/li><\/ul><\/li><li>ethambutol<ul><li>optic neuritis: check visual acuity before and during treatment<\/li><\/ul><\/li><\/ul>","notes_hash":"0784e7395cb9987d82672f1bbbab1f84","knowledge_graph_node_id_link":1138,"links":"<table style='width:100%'><tr><td>Cochrane<\/td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_924\" data-linkid=\"924\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"\/><\/svg><\/button><span id=\"link_good_count_924\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">6<\/span><button type=\"button\" style=\"\" id=\"link_dislike_924\" data-linkid=\"924\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"\/><\/svg><\/button><span id=\"link_bad_count_924\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">8<\/span><\/td><\/tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"http:\/\/www.cochrane.org\/CD002244\/INFECTN_corticosteroids-managing-people-tuberculous-meningitis\">Corticosteroids for managing tuberculous meningitis<\/a><\/td><\/tr><\/table><br><br><table style='width:100%'><tr><td>NICE<\/td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_375\" data-linkid=\"375\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"\/><\/svg><\/button><span id=\"link_good_count_375\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">6<\/span><button type=\"button\" style=\"\" id=\"link_dislike_375\" data-linkid=\"375\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"\/><\/svg><\/button><span id=\"link_bad_count_375\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">6<\/span><\/td><\/tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"https:\/\/www.nice.org.uk\/guidance\/ng33\/chapter\/Recommendations\">2016 Tuberculosis guidelines<\/a><\/td><\/tr><\/table>","media":"<table><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https:\/\/www.youtube.com\/embed\/6P6zBHpWiGA\" data-description=\"Tuberculosis\" data-upvotes=\"0\" data-downvotes=\"0\" data-media=\"1231\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https:\/\/i1.ytimg.com\/vi\/6P6zBHpWiGA\/mqdefault.jpg\" style=\"max-width:150px;\"><\/a><\/td><\/tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https:\/\/www.youtube.com\/embed\/6P6zBHpWiGA\" data-description=\"Tuberculosis\" data-upvotes=\"0\" data-downvotes=\"0\" data-media=\"1231\">Tuberculosis<\/a><\/td><\/tr><tr><td><span ><small>Osmosis - YouTube<\/small><\/span><\/td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_2166\" data-mediaid=\"2166\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"\/><\/svg><\/button><span id=\"media_good_count_2166\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">0<\/span><button type=\"button\" style=\"\" id=\"media_dislike_2166\" data-mediaid=\"2166\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"\/><\/svg><\/button><span id=\"media_bad_count_2166\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">0<\/span><\/td><\/tr><\/table>","concepts_for_notes":[],"category_name":"Infectious disease \/ Haematology \/ Immunology","subcategory_name":"Infectious disease","comment_count":11},"",[]]